Eledon Pharmaceuticals is a clinical stage biotechnology company with immunology expertise that is developing therapies to protect and prevent rejection of transplanted organs, as well as to treat amyotrophic lateral sclerosis (ALS). The Company’s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand (also called “CD154”), a well-validated biological target with broad therapeutic potential.
Company Details
- Employees
- 38
- Founded
- -
- Address
- 19900 Macarthur Blvd, 550,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://eledon.com
- HQ
- Irvine, California
Eledon Pharmaceuticals, Inc. Questions
Eledon Pharmaceuticals, Inc.'s website is https://eledon.com
Eledon Pharmaceuticals, Inc.'s LinkedIn profile is https://www.linkedin.com/company/eledon-pharma
Eledon Pharmaceuticals, Inc. has
38 employees.
View email and phone details for 38
employees at Eledon Pharmaceuticals, Inc..
Eledon Pharmaceuticals, Inc.'s industry is
Pharmaceutical Manufacturing
Eledon Pharmaceuticals, Inc.'s top competitors are
Mediar Therapeutics,
Seismic Therapeutic,
Zenon Biotech,
United Therapeutics Corporation,
Alnylam Pharmaceuticals,
Vertex Pharmaceuticals,
Climb Bio,
Egenesis, Inc.,
Imbria Pharmaceuticals,
A2 Biotherapeutics, Inc..
Eledon Pharmaceuticals, Inc.'s categories are Pharmaceutical Manufacturing
Eledon Pharmaceuticals, Inc.'s founding year is 2020
